MASLD tends to progress in NASH due to oxidative stress and inflammation that occur in the liver, which, together with lipotoxicity, aggravate insulin resistance, forming a vicious circle. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.